Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
life sciences
national
national blog main
9
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
9
×
seattle top stories
texas blog main
texas top stories
9
×
wisconsin blog main
wisconsin top stories
indiana blog main
indiana top stories
fda
clinical trials
cancer
eli lilly
ipo
merck
pfizer
abbvie
alzheimer's disease
astrazeneca
boehringer ingelheim
bristol-myers squibb
cancer immunotherapy
What
week
9
×
bio
roundup
ipo
life
moves
science
companies
drug
biogen
biotechs
ceo
debut
firms
group
medical
public
sciences
therapeutics
way
acquisitions
adu
alzheimer’s
america
annual
approved
arena’s
assessed
attention
beats
bids
big
biggest
biotech
black
bosley's
bosley’s
bounty
bridge
bucks
Language
unset
Current search:
week
×
biotech
×
" texas top stories "
×
" seattle blog main "
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M